Answers
#1 in Business Subscribe Email Print

You are here: Home > Legal > Cyber Law > The CAN SPAM Act of 2003

Tags

  • email
  • information
  • regulatory
  • developing combination
  • developing combination
  • developing combination

  • Links

  • Why Does It Seem That There Are More Children With ADHD Than Ever Before?
  • Google To Implement Universal Search
  • Breakthrough Spiritual Research on the Root Cause of Addictions
  • Answers - The CAN SPAM Act of 2003

    The CAN SPAM Act of 2003 is an acronym for Controlling the Assault of Non-Solicited Pornograph
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    y and Marketing Act which became effective January 1, 2004. The said legislation sets the req
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    irements for commercial emails and as well the penalties for the violators.

    CAN SPAM Act of 2
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    03 permits unsolicited mailing as long as the sender practices the agreed upon requirements fo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    commercial emails. These agreed upon requirements include clarity that the message is an adv
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    rtisement, accurate header information on which the email and IP addresses of the sender can b
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    e tracked. CAN SPAM Act also requires an explicit way for opting out and stop further mailings
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    Whenever an email contains adult content, the sender should place a message prompt or the lik
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    in the subject line to warn the reader. A misleading subject line is discouraged.

    Furthermor
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    , commercial emails sent to addresses compiled without permission, such as by automation and e
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ail address generation using ‘dictionary attack’ (combination of names, letters and numbers in
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    to multiple permutations) are prohibited. In addition, aggravated offense such as hijacking co
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    puters through Trojan or worms or using open mail relays for sending spam is also prohibited.
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    The content is exempted if it is purely religious, or if the content complies with the marketi
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    g mechanism specified by the law. Messages with national security content are also exempted.

    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    o understand more about the CAN SPAM Act of 2003 – the governing bodies, the penalties, reacti
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.answers.org.ua/article/129486/answers-The-CAN-SPAM-Act-of-2003.html">The CAN SPAM Act of 2003</a>

    BB link (for phorums):
    [url=http://www.answers.org.ua/article/129486/answers-The-CAN-SPAM-Act-of-2003.html]The CAN SPAM Act of 2003[/url]

    Related Articles:

    Medical Billing - EA1 Record Fields 1 Through 13

    The Things You Dont Like About Other People Say More About You Than It Does About Them!

    List Building to Promote your Product I

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com